KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Major Shareholder Venrock Healthcare Capital Par Acquires 20,686 Shares
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par purchased 20,686 shares of the business’s stock in a transaction dated Wednesday, January 24th. The stock was purchased at an average price of $12.44 per share, for a total transaction of $257,333.84. Following the completion of the acquisition, the insider now […]
More Stories
Alaska Governor Orders Probe Over Claims Democrats Recruited Senate Spoiler Candidate
By Tom Ozimek Alaska Gov. Mike Dunleavy has ordered the state to investigate whether aides to U.S. Senate hopeful Mary...
EU Proposes Giving Border Agency Frontex More Powers to Deport Illegal Immigrants
By Victoria Friedman The European Union has proposed giving the bloc’s border agency more powers, including the ability to take...
DoorDash Agrees to Buy Instacart in $17 Billion Deal to Expand Grocery Delivery
By Evgenia Filimianova DoorDash is offering $17 billion to buy grocery delivery company Instacart, potentially bringing together two of the...
US Economy Gains Momentum as 3rd-Quarter GDP Grows Better-Than-Expected 3.4 Percent
By Andrew Moran The U.S. economy recorded its best quarter in a year as consumer spending and business investment lifted...
The Diplomat Season 5 Renewed! Release Date, Cast, Plot, and More
The Diplomat, an American political thriller series, has captivated viewers since 2023. Four seasons have already aired, and fans are...
175 House Democrats Call for Halt to Ilhan Omar Investigation
By Guy Birchall Scores of House Democrats have called for an end to the federal investigation into Rep. Ilhan Omar...